Pfizer sells midphase inflammatory drugs to mystery startup, exiting race against Bristol Myers
Pfizer sells midphase inflammatory drugs to mystery startup, exiting race [...]
Pfizer sells midphase inflammatory drugs to mystery startup, exiting race [...]
Legend’s status put on hold as FDA delays Janssen-partnered CAR-T [...]
Novartis makes protein degrader play, inking deal with new British [...]
MIT team uncovers differences in T cells that drive immuno-oncology [...]
Lengo’s hiring spree shows no signs of slowing as it [...]
Zaks, fresh from making millions at Moderna, takes venture partner [...]
Signet Therapeutics gets a $10M top-up for next-gen cancer bets [...]
Daiichi jettisons ADC after flunking early solid tumor test ntaylor [...]
Gilead taps brakes on $4.9B bet after rival’s failure, pushing [...]
A COVID-19 vaccine delivered with a patch rivals traditional shots [...]